Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and Pioglitazone

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kim, Myung Sunny ^a,b   Yamamoto, Yasuhiko ^a,c   Kim, Kyungjin ^a,d   Kamei, Nozomu ^a,e   Shimada, Takeshi ^a,f   Liu, Libin ^a   Moore, Kristin ^a   Woo, Ju Rang ^a   Shoelson, Steven E ^a   Lee, Jongsoon ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Korea Food Research Institute   (South Korea)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d CJ Corporation   (South Korea)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

^f WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; CARBOXYLESTERASE; CATHEPSIN K; CLUSTERIN; COMPLEMENT FACTOR D; CYSTEINE RICH SECRETORY PROTEIN; DIAZEPAM BINDING INHIBITOR; FIBROBLAST GROWTH FACTOR; GAMMA GLUTAMYLCYCLOTRANSFERASE; HOMEODOMAIN PROTEIN; I KAPPA B; IMMUNOGLOBULIN LAMBDA CHAIN; INSULIN; INTERLEUKIN 7 RECEPTOR; KINESIN; LACTATE DEHYDROGENASE; LIPOPROTEIN LIPASE; MACROPHAGE ELASTASE; PIOGLITAZONE; PROTAMINE; RIBONUCLEASE A; RING FINGER PROTEIN; SALICYLIC ACID DERIVATIVE; SECRETORY PROTEIN; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; STROMELYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; UROPLAKIN 3; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MODEL; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LYMPHOCYTE COUNT; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; TREATMENT OUTCOME; ANIMAL; DNA MICROARRAY; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIGENE FAMILY; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; CELL COUNT; DIET, HIGH-FAT; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MULTIGENE FAMILY; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SALICYLATES; THIAZOLIDINEDIONES;

EID: 84893465131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082847     Document Type: Article

References (30)

1. Romeo GR, Lee J, Shoelson SE (2012) Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 32: 1771-1776.
2. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18: 363-374.
3. Chawla A, Nguyen KD, Goh YP (2011) Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 11: 738-749.
4. Lee B-C, Lee J (2013) Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta in press.
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
6. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
7. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR (2007) Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56: 16-23.
8. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309.
9. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, et al. (2001) Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of IKK b. Science 293: 1673-1677.
10. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, et al. (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108: 437-446.
11. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198.
12. Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, et al. (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 1: 36-43.
13. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, et al. (2010) The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 152: 346-357.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
15. Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 107: 240-245.
16. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
17. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117: 185-194.
18. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, et al. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117: 195-205.
19. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27: 669-692.
20. Kullo IJ, Hensrud DD, Allison TG (2002) Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30,>or = 30). Am J Cardiol 89: 1441-1443.
21. Kiermayer C, Conrad M, Schneider M, Schmidt J, Brielmeier M (2007) Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis 45: 11-16.
22. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, et al. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353: 1649-1652.
23. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, et al. (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 455-461.
24. Friedman GD, Klatsky AL, Siegelaub AB (1974) The leukocyte count as a predictor of myocardial infarction. N Engl J Med 290: 1275-1278.
25. Gillum RF, Mussolino ME, Madans JH (2005) Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 15: 266-271.
26. Grimm RH, Jr., Neaton JD, Ludwig W (1985) Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. J Am Med Assoc 254: 1932-1937.
27. Goldfine AB, Fonseca V, Jablonski KA, Chen Y-DI, Tipton L, et al. (2013) Salicylate (Salsalate) in Patients With Type 2 DiabetesA Randomized Trial. Ann Intern Med 159: 1-12.
28. Berria R, Glass L, Mahankali A, Miyazaki Y, Monroy A, et al. (2007) Reduction in hematocrit and hemoglobin following Pioglitazone treatment is not hemodilutional in Type II diabetes mellitus. Clin Pharmacol Ther 82: 275-281.
29. Agarwal R (2006) Anti-inflammatory effects of short-term Pioglitazone therapy in men with advanced diabetic nephropathy. Am J Physiol Renal Physiol 290: F600-605.
30. Bays H, McElhattan J, Bryzinski BS (2007) A double-blind, randomised trial of tesaglitazar versus Pioglitazone in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 4: 181-193.